These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. UNOS Liver Registry: ten year survivals. Waki K. Clin Transpl; 2006 Jan; ():29-39. PubMed ID: 18368704 [Abstract] [Full Text] [Related]
23. [The value of MELD in the allocation of priority for liver transplantation candidates]. Colmenero J, Castro-Narro G, Navasa M. Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411 [Abstract] [Full Text] [Related]
24. Using elderly donors in liver transplantation. Grazi GL, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna AD. Transplant Proc; 2005 Apr; 37(6):2582-3. PubMed ID: 16182750 [Abstract] [Full Text] [Related]
25. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253 [Abstract] [Full Text] [Related]
26. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU. Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732 [Abstract] [Full Text] [Related]
27. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Briceño J, Padillo J, Rufián S, Solórzano G, Pera C. Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807 [Abstract] [Full Text] [Related]
28. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Liver Transpl; 2005 Nov; 11(11):1425-30. PubMed ID: 16237709 [Abstract] [Full Text] [Related]
29. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. Avolio AW, Agnes S, Gasbarrini A, Nure E, Siciliano M, Castagneto M. Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263 [Abstract] [Full Text] [Related]
31. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Briceño J, Ciria R, de la Mata M, Rufián S, López-Cillero P. Transplantation; 2010 Sep 15; 90(5):530-9. PubMed ID: 20581766 [Abstract] [Full Text] [Related]
32. Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation. Yoshizumi T, Taketomi A, Soejima Y, Uchiyama H, Ikegami T, Harada N, Kayashima H, Yamashita Y, Shimada M, Maehara Y. Transpl Int; 2008 Jan 15; 21(1):81-8. PubMed ID: 17887958 [Abstract] [Full Text] [Related]
33. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Transplant Proc; 2007 Jun 15; 39(5):1501-4. PubMed ID: 17580172 [Abstract] [Full Text] [Related]
34. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption. Barone M, Avolio AW, Di Leo A, Burra P, Francavilla A. Transplantation; 2008 Mar 27; 85(6):844-9. PubMed ID: 18360266 [Abstract] [Full Text] [Related]
35. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Liver Transpl; 2007 Nov 27; 13(11):1564-9. PubMed ID: 17969210 [Abstract] [Full Text] [Related]
37. Model for end-stage liver disease can predict very early outcome after liver transplantation. Briceño J, Sánchez-Hidalgo JM, Naranjo A, Ciria R, Pozo JC, Luque A, de la Mata M, Rufián S, López-Cillero P. Transplant Proc; 2008 Nov 27; 40(9):2952-4. PubMed ID: 19010157 [Abstract] [Full Text] [Related]
38. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Hepatology; 2004 Jan 27; 39(1):230-8. PubMed ID: 14752842 [Abstract] [Full Text] [Related]
39. Advanced donor age alone does not affect patient or graft survival after liver transplantation. Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC. J Am Coll Surg; 2008 Dec 27; 207(6):847-52. PubMed ID: 19183530 [Abstract] [Full Text] [Related]
40. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Ann Surg; 2007 Dec 27; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]